Browse 17 Biotechnology companies funded by General Atlantic. See funding amounts, founder contacts, and investment details.
Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.
SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases.
Allonnia is an environmental biotechnology company focused on metals and mining, plastics and PFAS, plus other emerging contaminants.
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.
Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.
Ocumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies.
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.
Kalbe Genexine Biologics is developing innovative biologic therapy for high unmet medical needs in largely underserved areas.
View all companies funded by General Atlantic across every industry and funding stage.
View Full General Atlantic Portfolio